A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.

A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches. - A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046687

Enrollment

350

Registered

2022-02-01

Start date

2022-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Men and women aged 18 and over 2)A history of atherosclerotic cardiovascular disease(angina pectoris, myocardial infarction,cerebral infarction,or symptomatic peripheral arterial disease)in the past 10 years 3)LDL-C between 70 and 240 mg/dl at Visit 1 (pre-SCR) 4)Patients with dyslipidemia

Exclusion criteria

Exclusion criteria: 1)Triglyceride level over 400 mg/dl at Visit 1(pre-SCR) 2)A history of malignant tumor within 5 years before screening 3)Persons deemed ineligible by the study physician

Design outcomes

Primary

Measure	Time frame
To understand the recognition status of lipid management target values at the time of obtaining consent and the actual percentage of patients achieving lipid management target values. The amount of change in lipid parameters (LDLC (mg/dl), HDL-C (mg/dl), Non-HDL-C (mg/dl), TG (mg/dl)) set as lipid management targets and the percentage of patients achieving lipid management targets.	—

Secondary

Measure	Time frame
Changes in amount of blood pressure and body weight	—

Countries

Japan

Contacts

Public ContactYuichi Takahashi

Medical Corporation Chiseikai Tokyo Center Clinic Clinical Research Group

takahashi-yuichi@tc-clinic.jp0332766935

Outcome results